Local pharma formulators to benefit from new USFDA generic guidance: Report

This will help domestic pharma formulators with pending ANDA approvals to reduce review cycles and expedite approvals, says a weekend report by India Ratings.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2D8uWtN
via IFTTT